Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

ConditionsBorderline Resectable Pancreatic Ductal Adenocarcinoma Resectable Pancreatic Ductal Adenocarcinoma Stage I Pancreatic Cancer AJCC v8

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorEmory University

About this trial

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.

Eligibility criteria

Qualifiers

* Age ≥ 18 years with signed informed consent form

Patients must have a histological diagnosis of PDAC

Resectable or borderline resectable PDAC on imaging

Disqualifiers

* Patients with locally advanced and metastatic stage IV PDAC

Patients who have already received or completed neoadjuvant chemotherapy for PDAC

Patients with active malignancy receiving systemic therapy

Trial design

Treatments tested in this trial

Non-Interventional Study

Treatment groups

87 Participants

are divided into 1 treatment group

Locations

Emory University Hospital/Winship Cancer Institute30322, AtlantaGeorgia, United States

Sponsors and collaborators

Emory University

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov